vs
FARMER BROTHERS CO（FARM）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是FARMER BROTHERS CO的1.4倍（$127.1M vs $88.9M），再鼎医药同比增速更快（17.1% vs -1.2%），FARMER BROTHERS CO自由现金流更多（$-2.6M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs 2.1%）
Farmer Bros. Co.是一家总部位于美国得克萨斯州沃斯堡的餐饮服务企业，主打咖啡与茶类产品的生产分销，同时还供应约300种餐厅及其他经营场所所需的餐饮配套用品，目前由约翰·摩尔担任公司首席执行官兼总裁。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
FARM vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.4倍
$88.9M
营收增速更快
ZLAB
高出18.3%
-1.2%
自由现金流更多
FARM
多$24.1M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
2.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $88.9M | $127.1M |
| 净利润 | $-4.9M | — |
| 毛利率 | 36.3% | 51.0% |
| 营业利润率 | -4.7% | -54.6% |
| 净利率 | -5.5% | — |
| 营收同比 | -1.2% | 17.1% |
| 净利润同比 | -2417.1% | — |
| 每股收益（稀释后） | $-0.22 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FARMZLAB
| Q4 25 | $88.9M | $127.1M | ||
| Q3 25 | $81.6M | $115.4M | ||
| Q2 25 | $85.1M | $109.1M | ||
| Q1 25 | $82.1M | $105.7M | ||
| Q4 24 | $90.0M | $108.5M | ||
| Q3 24 | $85.1M | $101.8M | ||
| Q2 24 | $84.4M | $100.1M | ||
| Q1 24 | $85.4M | $87.1M |
净利润FARMZLAB
| Q4 25 | $-4.9M | — | ||
| Q3 25 | $-4.0M | $-36.0M | ||
| Q2 25 | $-4.7M | $-40.7M | ||
| Q1 25 | $-5.0M | $-48.4M | ||
| Q4 24 | $210.0K | — | ||
| Q3 24 | $-5.0M | $-41.7M | ||
| Q2 24 | $-4.6M | $-80.3M | ||
| Q1 24 | $-682.0K | $-53.5M |
毛利率FARMZLAB
| Q4 25 | 36.3% | 51.0% | ||
| Q3 25 | 39.7% | 59.5% | ||
| Q2 25 | 44.9% | 60.6% | ||
| Q1 25 | 42.1% | 63.6% | ||
| Q4 24 | 43.1% | 61.5% | ||
| Q3 24 | 43.9% | 64.1% | ||
| Q2 24 | 38.8% | 64.9% | ||
| Q1 24 | 40.1% | 61.4% |
营业利润率FARMZLAB
| Q4 25 | -4.7% | -54.6% | ||
| Q3 25 | -3.9% | -42.3% | ||
| Q2 25 | 4.6% | -50.3% | ||
| Q1 25 | -4.3% | -53.3% | ||
| Q4 24 | 1.1% | -62.6% | ||
| Q3 24 | -3.3% | -66.6% | ||
| Q2 24 | -4.9% | -76.0% | ||
| Q1 24 | -0.5% | -80.7% |
净利率FARMZLAB
| Q4 25 | -5.5% | — | ||
| Q3 25 | -4.9% | -31.2% | ||
| Q2 25 | -5.6% | -37.3% | ||
| Q1 25 | -6.1% | -45.8% | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | -5.9% | -40.9% | ||
| Q2 24 | -5.4% | -80.2% | ||
| Q1 24 | -0.8% | -61.4% |
每股收益（稀释后）FARMZLAB
| Q4 25 | $-0.22 | $-0.05 | ||
| Q3 25 | $-0.19 | $-0.03 | ||
| Q2 25 | $-0.22 | $-0.04 | ||
| Q1 25 | $-0.23 | $-0.04 | ||
| Q4 24 | $0.01 | $-0.09 | ||
| Q3 24 | $-0.24 | $-0.04 | ||
| Q2 24 | $-0.23 | $-0.08 | ||
| Q1 24 | $-0.03 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.2M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $35.7M | $715.5M |
| 总资产 | $151.4M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FARMZLAB
| Q4 25 | $4.2M | $689.6M | ||
| Q3 25 | $3.8M | $717.2M | ||
| Q2 25 | $6.8M | $732.2M | ||
| Q1 25 | $4.1M | $757.3M | ||
| Q4 24 | $5.5M | $779.7M | ||
| Q3 24 | $3.3M | $616.1M | ||
| Q2 24 | $5.8M | $630.0M | ||
| Q1 24 | $5.5M | $650.8M |
股东权益FARMZLAB
| Q4 25 | $35.7M | $715.5M | ||
| Q3 25 | $40.0M | $759.9M | ||
| Q2 25 | $43.5M | $791.7M | ||
| Q1 25 | $37.3M | $810.8M | ||
| Q4 24 | $41.5M | $840.9M | ||
| Q3 24 | $40.9M | $667.7M | ||
| Q2 24 | $45.5M | $704.2M | ||
| Q1 24 | $43.1M | $762.2M |
总资产FARMZLAB
| Q4 25 | $151.4M | $1.2B | ||
| Q3 25 | $158.8M | $1.2B | ||
| Q2 25 | $161.2M | $1.2B | ||
| Q1 25 | $163.2M | $1.2B | ||
| Q4 24 | $179.1M | $1.2B | ||
| Q3 24 | $182.0M | $985.3M | ||
| Q2 24 | $185.2M | $987.4M | ||
| Q1 24 | $179.1M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-786.0K | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $-2.6M | $-26.7M |
| 自由现金流率自由现金流/营收 | -2.9% | -21.0% |
| 资本支出强度资本支出/营收 | 2.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-158.9M |
8季度趋势，按日历期对齐
经营现金流FARMZLAB
| Q4 25 | $-786.0K | $-26.0M | ||
| Q3 25 | $-5.0M | $-32.0M | ||
| Q2 25 | $9.7M | $-31.0M | ||
| Q1 25 | $1.3M | $-61.7M | ||
| Q4 24 | $2.6M | $-55.8M | ||
| Q3 24 | $2.5M | $-26.8M | ||
| Q2 24 | $-995.0K | $-42.2M | ||
| Q1 24 | $-2.3M | $-90.1M |
自由现金流FARMZLAB
| Q4 25 | $-2.6M | $-26.7M | ||
| Q3 25 | $-6.9M | $-35.0M | ||
| Q2 25 | — | $-33.9M | ||
| Q1 25 | $-684.0K | $-63.2M | ||
| Q4 24 | $521.0K | $-58.4M | ||
| Q3 24 | $-837.0K | $-28.2M | ||
| Q2 24 | — | $-42.9M | ||
| Q1 24 | $-5.7M | $-91.1M |
自由现金流率FARMZLAB
| Q4 25 | -2.9% | -21.0% | ||
| Q3 25 | -8.5% | -30.4% | ||
| Q2 25 | — | -31.1% | ||
| Q1 25 | -0.8% | -59.9% | ||
| Q4 24 | 0.6% | -53.8% | ||
| Q3 24 | -1.0% | -27.7% | ||
| Q2 24 | — | -42.9% | ||
| Q1 24 | -6.7% | -104.5% |
资本支出强度FARMZLAB
| Q4 25 | 2.1% | 0.5% | ||
| Q3 25 | 2.4% | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | 2.4% | 1.5% | ||
| Q4 24 | 2.3% | 2.4% | ||
| Q3 24 | 3.9% | 1.3% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | 4.0% | 1.1% |
现金转化率FARMZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 12.16× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FARM
| Coffee Roasted | $45.5M | 51% |
| Tea Iced Hot | $23.3M | 26% |
| Culinary | $14.1M | 16% |
| Spice | $4.9M | 5% |
| Fuel Surcharge | $1.2M | 1% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
